I don't think anyone is expecting the SP to rocket on the back of the FDA minutes - I certainly am not.
I think the FDA minutes will provide significant guidance on what the future looks like for PMS and by inference, the various other conditions we are trialling. That will inform trial costs and parameters, likelihood of success, preferred strategic direction.
It is very important and instructive, without necessarily being directly impactful on the SP.
That's my view.
Share Price, page-12148
-
- There are more pages in this discussion • 716 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.40 |
Change
1.130(8.52%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $13.80 | $14.45 | $13.53 | $15.04M | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 871 | $14.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.42 | 3650 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |